(Q67453807)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1271890%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

title

Hazards and complications of BCG immunotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1271890%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

Hazards and Complications of BCG Immunotherapy (English)

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31894-6

17 November 2023

1 reference

F. C. Sparks

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1271890

7 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1271890

7 September 2022

publication date

1 May 1976

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1271890%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

13 September 2019

https://api.elsevier.com/content/article/PII:S0025712516318946?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31894-6

https://api.elsevier.com/content/article/PII:S0025712516318946?httpAccept=text/plain

17 November 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31894-6

Medical Clinics of North America

17 November 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1271890%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

volume

60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1271890%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1271890%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

page(s)

499-509

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1271890%20AND%20SRC:MED&resulttype=core&format=json

Complications of BCG vaccination in neoplastic disease

13 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931894-6

BCG immunotherapy of pulmonary growths from intravenously transferred rat tumour cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931894-6

Hepatic Granulomas and Other Hepatic Lesions Associated with BCG Immunotherapy for Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931894-6

CONGENITAL AGAMMAGLOBULINAEMIA IN THE BROTHER OF A BOY WHO DIED OF GENERALIZED BCG INFECTION.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931894-6

Brief communication: antigenic relationship between Mycobacterium bovis (BCG) and a guinea pig hepatoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931894-6

B.C.G. dissemination in congenital hypogammaglobulinaemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931894-6

Isoniazid toxicity. A prospective study in secondary chemoprophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931894-6

Regional lymphadenitis following BCG vaccination (BCGitis). Clinical comments based upon 25 instances among 1295 childhood vaccinees

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931894-6

Allergic reaction to B.C.G.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931894-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931894-6

Cell-mediated immunity to human tumors. Abrogation by serum factors and nonspecific effects of oral BCG therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931894-6

BCG-Osteomyelitis and -Osteoarthritis as a Complication Following BCG-Vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931894-6

Aerosol BCG treatment of carcinoma metastatic to the lung: A phase I study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931894-6

Immunotherapy combined with primary resection of murine fibrosarcoma: correlation of immunological status of the host with prevention of metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931894-6

Results of administering B.C.G. to patients with melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931894-6

Active immunotherapy with B.C.G. for recurrent malignant melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931894-6

Granulomatous hepatitis: a complication of B.C.G. immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931894-6

Letter: Stop isoniazid prophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931894-6

Serum-mediated blocking of cell-mediated anti-tumor immunity in a melanoma patient: Association with BCG immunotherapy and clinical deterioration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931894-6

Immunotherapy of melanoma with BCG: Two fatalities following intralesional injection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931894-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931894-6

7 January 2021

Letter: Reactions to BCG

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931894-6

Pulmonary tuberculosis due to B.C.G

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931894-6

Enhanced tumor growth in animals pretreated with complete Freund's adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931894-6

Systemic infection following BCG therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931894-6

Serum transaminase elevations and other hepatic abnormalities in patients receiving isoniazid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931894-6

Complications of BCG immunotherapy in patients with cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931894-6

Isoniazid Hepatitis: Backlash of Progress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931894-6

Letter: Isoniazid hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931894-6

Bacterial metastasis following B.C.G.-vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931894-6

BCG immunotherapy of rat tumors of defined immunogenicity

7 January 2021

4

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31894-6

Immunotherapy of melanoma with intralesional BCG

17 November 2023

8

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31894-6

Immunological tumor enhancement and in vitro cytotoxicity. Further evidence for the involvement of 7S 2a-immunoglobulin

17 November 2023

18

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31894-6

A fatality from BCG vaccination

17 November 2023

28

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31894-6

The safety record of BCG vaccination and untoward reactions observed after vaccination

17 November 2023

29

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31894-6

Lupus vulgaris and multiple bone lesions caused by BCG

17 November 2023

31

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31894-6

A fatal case of tuberculosis produced by BCG

17 November 2023

41

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31894-6

Regression of intradermal malignant melanoma after intralesional injection of Mycobacterium bovis strain BCG

17 November 2023

43

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31894-6

The role of the reticuloendothelial system in the host reaction to neoplasia

17 November 2023

44

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31894-6

Treatment of malignant melanoma by intratumoral injection of BCG

17 November 2023

46

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31894-6

Does isoniazid decrease the effect of BCG on local tumor growth?

17 November 2023

50

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31894-6

Autoimmunity and the skin

17 November 2023

61

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31894-6

17 November 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1271890%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

1 reference